Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH — Stella

Recruiting

Back to Neonatal Hyperbilirubinemia trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

Women's Hospital School of Medicine Zhejiang University, Hangzhou

Key details

Phase

Very early testing

Sponsor

Women's Hospital School Of Medicine Zhejiang University

Enrollment target

~250 participants

Started

July 2025

Primary completion

December 2026

Age range

4 Hours – 28 Days

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov